Prevalence of mental health conditions among people living with HIV during the COVID-19 pandemic: A rapid systematic review and meta-analysis.

Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1293 (Electronic) Linking ISSN: 14642662 NLM ISO Abbreviation: HIV Med Subsets: MEDLINE

Publication: Oxford : Wiley
Original Publication: Oxford : Blackwell Science, c1999-

COVID-19*/epidemiology ; HIV Infections*/complications ; HIV Infections*/epidemiology; Anxiety/epidemiology ; Depression/diagnosis ; Depression/epidemiology ; Humans ; Mental Health ; Pandemics ; Prevalence

Background: The COVID-19 pandemic has generated many mental health problems worldwide. People living with HIV (henceforth known as PLHIV) bear a higher mental health burden in comparison with the general population. Therefore, their risk of mental health problems may be elevated during the pandemic.
Methods: We conducted a systematic review and meta-analysis to assess the prevalence of depression, anxiety, psychological stress, insomnia and loneliness among PLHIV during the COVID-19 pandemic. Observational studies in four databases published from 1 January 2020 to 30 April 2021 investigating the prevalence of mental health conditions during the COVID-19 pandemic were searched, and 197 articles were retrieved. After the processes of duplication removal, eligibility screening and full-text assessment, 10 articles were included in the systematic review and six articles for meta-analyses. A random-effects model was applied to derive the pooled prevalence of mental health conditions. The risk of bias was assessed using the STROBE checklist.
Results: Overall, the pooled prevalence rates of (moderate-to-severe) depression and anxiety among PLHIV were 16.9% [95% confidence interval (CI): 3.8%-30.0%] and 23.0% (95% CI: 12.0%-34.0%), respectively.
Conclusions: More research is needed to investigate the mechanism by which the pandemic affects the mental health of PLHIV. Support and programmes are needed to ameliorate the mental health problems in this marginalized population.
(© 2022 British HIV Association.)

J Acquir Immune Defic Syndr. 2020 Dec 1;85(4):475-482. (PMID: 33136748)
Death Stud. 2012 Aug;36(7):640-63. (PMID: 24563943)
Infect Chemother. 2013 Jun;45(2):211-6. (PMID: 24265969)
Lancet. 2020 Mar 21;395(10228):931-934. (PMID: 32164834)
AIDS. 2019 Jul 15;33(9):1411-1420. (PMID: 30950883)
AIDS Behav. 2012 Oct;16(7):1862-9. (PMID: 21986868)
Health Psychol. 2018 Jun;37(6):574-585. (PMID: 29781655)
BMC Psychiatry. 2018 May 31;18(1):160. (PMID: 29855289)
Lancet. 2020 Mar 14;395(10227):912-920. (PMID: 32112714)
BMC Public Health. 2020 Oct 23;20(1):1598. (PMID: 33097028)
JAMA Intern Med. 2020 Jun 1;180(6):817-818. (PMID: 32275292)
AIDS Care. 2014 Apr;26(4):505-13. (PMID: 23998905)
J Epidemiol Community Health. 2015 Mar;69(3):284-9. (PMID: 25385745)
Int J Environ Res Public Health. 2021 Apr 27;18(9):. (PMID: 33925506)
J Acquir Immune Defic Syndr. 2021 Mar 1;86(3):e54-e60. (PMID: 33148994)
Am J Psychiatry. 2001 May;158(5):725-30. (PMID: 11329393)
Neuropsychology. 2019 Feb;33(2):212-221. (PMID: 30589284)
J Relig Health. 2020 Oct;59(5):2203-2204. (PMID: 32415426)
Int J Environ Res Public Health. 2020 Jun 24;17(12):. (PMID: 32599783)
AIDS Behav. 2019 Nov;23(11):2992-3001. (PMID: 31392442)
Lancet HIV. 2020 May;7(5):e308-e309. (PMID: 32272084)
J Clin Sleep Med. 2020 Aug 15;16(8):1417-1418. (PMID: 32351206)
AIDS. 2019 Sep 1;33(11):1781-1787. (PMID: 31211718)
J Neurovirol. 2021 Feb;27(1):168-170. (PMID: 33405207)
Pharmacol Biochem Behav. 2018 Jan;164:125-138. (PMID: 28843425)
Lancet Infect Dis. 2020 May;20(5):533-534. (PMID: 32087114)
Turk J Med Sci. 2020 Aug 11;50(8):1792-1800. (PMID: 32777899)
Syst Rev. 2015 Jan 01;4:1. (PMID: 25554246)
Lancet. 2007 Sep 8;370(9590):859-77. (PMID: 17804063)
AIDS Behav. 2021 Jan;25(1):68-72. (PMID: 32816193)
Psychiatr Rehabil J. 2015 Sep;38(3):249-55. (PMID: 25664756)
Am Psychol. 2020 Oct;75(7):897-908. (PMID: 32567879)
West J Med. 2000 Feb;172(2):124-8. (PMID: 10693376)
Ann Med Health Sci Res. 2013 Jul;3(3):380-4. (PMID: 24116318)
HIV Med. 2022 Oct;23(9):990-1001. (PMID: 35304829)
AIDS Behav. 2020 Oct;24(10):2975-2983. (PMID: 32246358)
Brain Behav Immun. 2020 Jul;87:49-50. (PMID: 32304883)
AIDS Behav. 2020 Aug;24(8):2236-2238. (PMID: 32303923)
BMC Med Res Methodol. 2009 Dec 04;9:80. (PMID: 19961608)
J Gen Intern Med. 2011 Oct;26(10):1175-82. (PMID: 21533823)
AIDS Care. 2012;24(7):866-76. (PMID: 22273149)
Int J Environ Res Public Health. 2018 Dec 17;15(12):. (PMID: 30562949)
Int J Behav Med. 2017 Aug;24(4):613-618. (PMID: 28124192)
AIDS Behav. 2020 Oct;24(10):2764-2765. (PMID: 32382824)
AIDS Care. 2010 Sep;22(9):1086-92. (PMID: 20824561)
PLoS One. 2017 Aug 4;12(8):e0181960. (PMID: 28783739)
AIDS Care. 2009 Aug;21(8):1007-13. (PMID: 20024757)
AIDS Behav. 2021 Aug;25(8):2391-2399. (PMID: 33630198)
MMWR Morb Mortal Wkly Rep. 2015 May 1;64(16):443-4. (PMID: 25928470)
World Psychiatry. 2015 Jun;14(2):231-3. (PMID: 26043341)
J Acquir Immune Defic Syndr. 2020 Nov 1;85(3):257-262. (PMID: 32826562)
Infez Med. 2021 Mar 1;29(1):54-64. (PMID: 33664173)
Sex Health. 2011 Dec;8(4):551-9. (PMID: 22127042)
Lancet Psychiatry. 2020 Oct;7(10):883-892. (PMID: 32707037)
Am J Public Health. 2020 Jan;110(1):37-44. (PMID: 31725317)
AIDS Behav. 2019 Mar;23(3):580-591. (PMID: 30269230)
Curr Psychiatry Rep. 2015 Jan;17(1):530. (PMID: 25413636)
Occup Med (Lond). 2010 Sep;60(6):423-9. (PMID: 20584766)
PLoS Med. 2007 Oct 16;4(10):e297. (PMID: 17941715)
BMJ Open. 2020 Apr 27;10(4):e032435. (PMID: 32345695)

Keywords: AIDS; COVID-19; HIV; anxiety; depression; insomnia; loneliness; meta-analysis; psychological distress; psychological stress; systematic review

Date Created: 20220319 Date Completed: 20220916 Latest Revision: 20221114

20221213

PMC9111307

10.1111/hiv.13299

35304829